Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1078303 | 0.75 | — | — | |
| SCHEMBL7153017 | 0.69 | — | — | |
| SCHEMBL13059648 | 0.69 | — | — | |
| SCHEMBL3264898 | 0.69 | SMN1; SMN2 (0.34) | — | |
| SCHEMBL16405076 | 0.67 | TSHR (0.35) | — | |
| SCHEMBL21582317 | 0.67 | GAA (0.32) | — | |
| SCHEMBL12156950 | 0.67 | TSHR (0.32) | — | |
| SCHEMBL5846168 | 0.65 | TSHR (0.40) | — | |
| SCHEMBL4271924 | 0.65 | TSHR (0.33) | LMNA | |
| SCHEMBL347199 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107847603-B | Liposome adjuvant composition | 硕腾服务有限责任公司 | 2021-05-11 | — | — | CN | disclosed |
| US-10092486-B2 | Polyurea or polyurethane capsules | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2018-10-09 | — | — | US | disclosed |
| EP-3186310-A1 | MODIFICATION OF ENGINEERING PLASTICS USING OLEFIN-MALEIC ANHYDRIDE COPOLYMERS | Vertellus Holdings LLC (US) | 2017-07-05 | — | — | EP | disclosed |
| EP-3140354-A1 | METHOD FOR DELIVERING ALUMINIUM INTO WATERBORNE TINT BASE OR PAINT AND REFINISH MIXER SYSTEM | BASF Coatings GmbH (DE) | 2017-03-15 | — | — | EP | disclosed |
| US-20160193122-A1 | POLYUREA OR POLYURETHANE CAPSULES | INTERNATIONAL FLAVORS AND FRAGRANCES INC. | 2016-07-07 | — | — | US | disclosed |
| WO-2016010893-A1 | MODIFICATION OF ENGINEERING PLASTICS USING OLEFIN-MALEIC ANHYDRIDE COPOLYMERS | VERTELLUS SPECIALTIES, INC. (US) | 2016-01-21 | — | — | WO | disclosed |
| WO-2015169502-A1 | METHOD FOR DELIVERING ALUMINIUM INTO WATERBORNE TINT BASE OR PAINT AND REFINISH MIXER SYSTEM | BASF COATINGS GMBH (DE) | 2015-11-12 | — | — | WO | disclosed |
| EP-2143759-A2 | Grafted cyclodextrin | Cellresin Technologies, LLC (US) | 2010-01-13 | — | — | EP | disclosed |
| EP-1247532-B1 | COMPOSITION PROMOTING LACRIMAL SECRETION | FUSO PHARMACEUTICAL IND (JP) | 2009-02-25 | — | — | EP | disclosed |
| US-7348306-B2 | Composition for promoting lacrimal secretion | FUSO PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 2008-03-25 | — | — | US | disclosed |
| US-4757091-A | Suspension polymerization of polyvinyl chloride in the presence of dispersant system | THE B.F. GOODRICH COMPANY (US) | 1988-07-12 | — | — | US | disclosed |
| US-4755538-A | Skinless porous particle PVC resin and process for producing same | THE B. F. GOODRICH COMPANY (US) | 1988-07-05 | — | — | US | disclosed |
| US-4755539-A | Skinless porous particle PVC resin and process for producing same | THE B. F. GOODRICH COMPANY (US) | 1988-07-05 | — | — | US | disclosed |
| US-4742085-A | POLYVINYL CHLORIDE | THE B. F. GOODRICH COMPANY (US) | 1988-05-03 | — | — | US | disclosed |
| US-4727091-A | CHARGING FREE RADICAL CATALYST AS SOLUTION HAVING LOWER DENSITY MONOMER SOLUTION | THE B. F. GOODRICH COMPANY (US) | 1988-02-23 | — | — | US | disclosed |
| US-4711908-A | Skinless porous particle PVC resin and process for producing same | THE B. F. GOODRICH COMPANY (US) | 1987-12-08 | — | — | US | disclosed |
| US-4699785-A | Cell line producing feline leukemia virus | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1987-10-13 | — | — | US | disclosed |
| EP-0239966-A2 | Improved process for producing porous spherical polyvinyl chloride particles | The B.F. GOODRICH Company (US) | 1987-10-07 | — | — | EP | disclosed |
| US-4684668-A | Process for producing porous spherical polyvinyl chloride particles | THE B. F. GOODRICH COMPANY (US) | 1987-08-04 | — | — | US | disclosed |
| US-4668707-A | EMULSION POLYMERIZATION, THICKENERS, CATALYST SOLUTION | THE B. F. GOODRICH COMPANY (US) | 1987-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160193122-A1 | POLYUREA OR POLYURETHANE CAPSULES | PARG, MUS81, CCNY | LMNA 1697/4885CYP2C9 1268/4885 |
| US-10092486-B2 | Polyurea or polyurethane capsules | PARG, MUS81, CCNY | LMNA 1697/4885CYP2C9 1268/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.